Enlivex terminated its agreement with the Rain Foundation for a private Placement of 66,666,667 ordinary shares payable in RAIN tokens. Investors are affected because the planned issuance will not proceed, and Enlivex will not seek Shareholder approval for the transaction.
Key Highlights
- The Rain Foundation had elected to use RAIN tokens for the proposed share purchase.
- Enlivex ended the agreement under its contractual termination rights on September 22, 2026.
- The planned transaction was subject to shareholder approval before completion.
Enlivex Ltd. (NASDAQ: ENLV) is a biotechnology company. It ended a proposed private placement involving 66,666,667 ordinary shares, removing the planned share issuance from the transaction described with the Rain Foundation. The agreement had been signed on July 27, 2026. The Rain Foundation was set to purchase the shares using RAIN tokens, subject to approval by Enlivex shareholders. Enlivex terminated the securities purchase agreement on September 22, 2026, exercising termination rights provided under the agreement. The company also issued a press release on that date concerning the decision.
Proposed Share Issuance Ends
The private placement will not be completed following the termination. Enlivex will not pursue shareholder approval for the transaction. The proposed buyer was the Rain Foundation, and the securities involved were ordinary shares. Enlivex’s stated action covers both the securities purchase agreement and the private placement contemplated by it.
FAQs
Q: What happened to Enlivex’s RAIN token private placement?
A: Enlivex terminated its agreement with the Rain Foundation. The planned private placement of 66,666,667 ordinary shares will not be completed.
Q: Will Enlivex shareholders vote on the proposed share issuance?
A: No. Enlivex said it will not seek shareholder approval for the private placement after ending the securities purchase agreement.
Q: Who was expected to buy Enlivex ordinary shares?
A: The Rain Foundation was the proposed purchaser. It had elected to acquire the ordinary shares using RAIN tokens under the private placement agreement.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.